Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

3365 results

Sort By:

Analgesic Effect of Parecoxib Versus Morphine in SCD Patients Presenting to the Emergency Department

Study ID: NCT06315920
Start Date: 2026-05-01
End Date: 2028-07-01
Study Type

Interventional

Study Phase

Phase3

No. of Participants

226

Intervention / Treatment

Parecoxib

Morphine

Sponsor

Oman Medical Speciality Board

Source: clinicaltrials.gov

Share:
Add to list

Implementing Team-Based Treatment for Pediatric Anxiety in Community Mental Health Settings

Study ID: NCT06934525
Start Date: 2025-11-01
End Date: 2029-08-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

501

Intervention / Treatment

Team-delivered, exposure-based CBT

Sponsor

Bradley Hospital

Source: clinicaltrials.gov

Share:
Add to list

Deep Brain Stimulation for Refractory Obsessive-Compulsive Disorder

Study ID: NCT06660225
Start Date: 2025-06
End Date: 2031-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

10

Intervention / Treatment

Medtronic Percept Deep Brain Stimulation Therapy [Sham Control Stimulation]

Medtronic Percept Deep Brain Stimulation Therapy [Therapeutic stimulation]

Sponsor

Nader Pouratian

Source: clinicaltrials.gov

Share:
Add to list

A Phase 2 Trial to Assess Safety and Efficacy of Tofacitinib 2% Cream in the Treatment of Cutaneous T-cell Lymphoma (CTCL), Stages IA, IB, and IIA

Study ID: NCT06698822
Start Date: 2025-05-06
End Date: 2026-10-19
Study Type

Interventional

Study Phase

Phase2

No. of Participants

20

Intervention / Treatment

tofacitinib 2% cream

Sponsor

M.D. Anderson Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Convenient Home Access for Routine Monitoring in Diabetes (Charm-D Study)

Study ID: NCT06695325
Start Date: 2025-06-01
End Date: 2025-12-15
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

300

Intervention / Treatment

HbA1c test

Sponsor

Tameside General Hospital

Source: clinicaltrials.gov

Share:
Add to list

Observational Copenhagen Pancreatic Cancer Study

Study ID: NCT06713525
Start Date: 2025-12
End Date: 2036-12
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

8000

Intervention / Treatment
Sponsor

Inna Chen, MD

Source: clinicaltrials.gov

Share:
Add to list

An Exploratory Clinical Study of the Efficiency and Safety of TH027 in the Treatment of Relapsed/Refractory Solid Tumors

Study ID: NCT06951425
Start Date: 2025-06-01
End Date: 2028-11-30
Study Type

Interventional

Study Phase

Early_phase1

No. of Participants

24

Intervention / Treatment

TH-CART-027

Sponsor

Shanghai Tongji Hospital, Tongji University School of Medicine

Source: clinicaltrials.gov

Share:
Add to list

A Phase II Study of Single Tremelimumab With Regular Interval Durvalumab Plus Gemcitabine and Cisplatin in Locally Advanced Unresectable/Metastatic Combined Hepatocellular-cholangiocarcinoma

Study ID: NCT06855225
Start Date: 2025-06
End Date: 2027-04
Study Type

Interventional

Study Phase

Phase2

No. of Participants

29

Intervention / Treatment

Tremelimumab

Durvalumab

Gemcitabine

Cisplatin

Sponsor

Mehmet action

Source: clinicaltrials.gov

Share:
Add to list

Post-marketing Surveillance Study for the Safety of Efluelda Tetra Pre-filled Syringe.

Study ID: NCT06694025
Start Date: 2025-10-01
End Date: 2030-12-05
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

670

Intervention / Treatment

Efluelda Tetra Pre-filled syringe

Sponsor

Sanofi

Source: clinicaltrials.gov

Share:
Add to list

Personalized NFTs as a Trial Participation Incentive

Study ID: NCT06647030
Start Date: 2025-07-02
End Date: 2026-06-02
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

15

Intervention / Treatment

CURATE.DTx sessions

Interview

Sponsor

Institute for Digital Medicine (WisDM)

Source: clinicaltrials.gov

Share:
Add to list